Studies have reported that TRAF2 plays a negative regulatory role in the expression of TLR-stimulated proinflammatory cytokines and inhibits the occurrence of colitis by reducing the expression of LPS-, poly(I:C)- and IL-1β-induced proinflammatory cytokines [33]. Here, TRAF2 is linked to colitis.